Objective: To measure perfusion in different lung cancer subtypes and compare results with histopathological/immunohistochemical results.
Methods: Seventy-two consecutive untreated patients with lung cancer (40 adenocarcinomas, 20 squamous cell, and 12 small cell lung cancers) were enrolled. A 40-second volume perfusion computed tomography of the tumor bulk was obtained.